BA could chemosensitize wt-EGFR lung cancer cells to gefitinib/osimertinib through direct binding to EGFR, triggering PI3K-AKT-mTOR axis-mediated autophagic cell death, consequently inducing cell cycle arrest and causing marked tumor regression in vivo. Here, AKT1 is linked to lung carcinoma.